Name: Latest research reports of Sanofi India Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Sanofi India Ltd.
Rating: 4
Author: ICICI Securities Limited

Sanofi India Ltd.

NSE: SANOFI | BSE: 500674 | ISIN: INE058A01010 | Industry: Pharmaceuticals
| Expensive Performer

6221.5000 14.50 (0.23%)

NSE Apr 17, 2025 15:31 PM

40.89% Fall from 52W High

Volume: 7,424

Sanofi India Ltd.

03 Mar 2022

6221.50

0.23%

Sanofi Q4CY21 concall highlights

Accumulate: Sanofi India Ltd.

Recommendation Target

ICICI Securities Limited

Sanofi India Limited (SANL) hosted an investor call to discuss the results for Q4CY21 and CY21. We have summarised the highlights below

Number of FII/FPI investors decreased from 186 to 172 in Dec 2024 qtr